Amgen Fremont Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 47208
 
  
 
C07K PEPTIDES 36100
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 23144
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8198
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS642
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 693
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
B82Y SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE  OR TREATMENT OF NANO-STRUCTURES251
 
  
 
B63B SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 137

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0218,067 Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses ThereofFeb 24, 17Aug 03, 17[A61K, G01N, C07K]
2016/0311,919 Antibodies Directed To GPNMB And Uses ThereofFeb 25, 16Oct 27, 16[A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9718883 Antibodies to M-CSFOct 27, 15Aug 01, 17[A61K, C07K]
9580503 Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofNov 29, 11Feb 28, 17[A61K, C07K]
9328169 Human antibodies that bind human MAdCAMJan 07, 05May 03, 16[A61K, C07K]
9238691 Nucleic acids encoding antibodies to CCR2Apr 03, 14Jan 19, 16[A61K, C07K]
RE45847 Antibodies to MAdCAMMar 19, 14Jan 19, 16[A61K, C12N, C07K]
9234041 Antibodies to insulin-like growth factor I receptorDec 19, 13Jan 12, 16[A61K, G01N, C07K]
9221915 Human monoclonal antibodies to activin receptor-like kinase-1Oct 26, 11Dec 29, 15[A61K, C07K]
9096672 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofMar 02, 09Aug 04, 15[A61K, B82Y, C07K]
9085624 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofNov 10, 08Jul 21, 15[A61K, B82Y, C07K]
9073998 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofMar 02, 09Jul 07, 15[A61K, B82Y, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0044,212 Antibodies Directed to GPNMB and Uses ThereofAbandonedAug 07, 14Feb 12, 15[A61K, C07K]
2014/0154,243 SPECIFIC BINDING AGENTS TO HEPATOCYTE GROWTH FACTORAbandonedNov 21, 13Jun 05, 14[A61K, C07K]
2014/0134,157 ANTIBODIES TO OPGLAbandonedMar 14, 13May 15, 14[C07K]
2014/0105,905 High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such AntibodiesAbandonedNov 20, 13Apr 17, 14[C07K]
2013/0344,514 REDUCING THE RISK OF HUMAN ANTI-HUMAN ANTIBODIES THROUGH V GENE MANIPULATIONAbandonedAug 23, 13Dec 26, 13[G01N]
8604174 High affinity fully human monoclonal antibodies to interleukin-8ExpiredApr 18, 06Dec 10, 13[A61K, C07K]
8597615 Methods of monitoring a human anti-human antibody response and inhibitors thereofExpiredMay 08, 12Dec 03, 13[A61K, A01K]
8568992 Antibody categorization based on binding characteristicsExpiredMay 24, 12Oct 29, 13[G01N]
2013/0024,956 ANTIBODIES TO CD40AbandonedSep 14, 12Jan 24, 13[A61K, C12P, C12N, A01K, A01H, A61P, A61N, C07K]
2012/0244,167 ANTIBODIES TO M-CSFAbandonedApr 27, 12Sep 27, 12[A61K, C12N, A61P, C07K]
8198508 Reducing the risk of human anti-human antibodies through V gene manipulationExpiredOct 12, 09Jun 12, 12[A61K, A01K]
7993643 Uses of human monoclonal antibodies against oxidized LDL receptorExpiredApr 26, 07Aug 09, 11[A61K, C07K]
7964193 Antibodies against interleukin-1 βExpiredJun 19, 09Jun 21, 11[A61K]
2011/0091,455 ANTIBODIES TO MYOSTATINAbandonedAug 26, 10Apr 21, 11[A61K, A61P]
2011/0064,726 ANTI IgE ANTIBODIESAbandonedNov 24, 10Mar 17, 11[A61K, C07H, C12P, C12N, A61P, C07K]
7867494 Anti-IgE antibodiesExpiredApr 01, 08Jan 11, 11[A61K]
2010/0098,694 ANTIBODIES TO CD40AbandonedOct 09, 09Apr 22, 10[A61K, C07H, C12P, C12N, A01K, A01H, A61P, C07K]
7625549 Determining the risk of human anti-human antibodies in transgenic miceExpiredMay 23, 05Dec 01, 09[A61K, A01K]
7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereofExpiredNov 17, 00Aug 25, 09[C12N, C07K]
7566772 Antibodies against interleukin-1βExpiredJan 19, 06Jul 28, 09[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.